Pilot Study - Monitoring the Nasal Microbiome and Viral Respiratory Infections in Newborn Hospitalized in Neonatalogy.
Not Applicable
Active, not recruiting
- Conditions
- Newborn; Infection
- Interventions
- Other: Nasal Swab
- Registration Number
- NCT06389383
- Lead Sponsor
- University Hospital, Caen
- Brief Summary
The objective of our study is therefore to study the evolution of the respiratory microbiome of hospitalized newborns, its interaction with viral infections and their impacts on the evolution of newborns.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 38
Inclusion Criteria
- Newborn hospitalized in intensive care or neonatal intensive care.
- Whose parents were able to be informed of the study and who signed consent.
- Parents affiliate to the social security system
Exclusion Criteria
- Refusal of parental consent
- Parents who are minors or under guardianship, curatorship, safeguard of justice or legal protection.
- Newborn having already left the hospital/returned home before inclusion
- Hospitalization beyond the first 48 hours of life
- Only palliative care.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Nasal swab Nasal Swab * Nasal swab once a week for the duration of the stay in intensive care unit/intensive care (procedure already carried out routinely to detect nasal staphylococcus once a week). * Nasal swab every 14 days when the newborn is hospitalized in routine care/kangaroo unit/hospitalization at home
- Primary Outcome Measures
Name Time Method rate of viral infections from baseline to end of hospitalization (up to 2 months)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
CAEN University Hospital
🇫🇷Caen, France